Niphakis, Micah J <br/><br/>
Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors.  [electronic resource] 

 -  ACS chemical neuroscience  Sep 2013 
 - 1322-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1948-7193 
<br/><br/><label>Standard No.: </label>10.1021/cn400116z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amidohydrolases--antagonists & inhibitors<br/>Animals<br/>Blood Glucose--analysis<br/>Brain--drug effects<br/>Carbamates--chemical synthesis<br/>Diabetes Mellitus, Type 2--blood<br/>Diabetic Neuropathies--blood<br/>Drug Evaluation, Preclinical<br/>Endocannabinoids--metabolism<br/>HEK293 Cells<br/>Humans<br/>Hyperalgesia--drug therapy<br/>Insulin--blood<br/>Liver--drug effects<br/>Male<br/>Mice<br/>Molecular Structure<br/>Monoacylglycerol Lipases--antagonists & inhibitors<br/>Nociception--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Species Specificity<br/>Structure-Activity Relationship<br/>Succinimides--chemistry